Foley Partners Judith Waltz and Antoinette Konski authored an article that appeared in Genetic Engineering & Biotechnology News on July 1, 2011 titled “HHS Puts Stamp on Personalized Medicine.” The authors discuss the Department of Health and Human Services’ (HHS) influence on personalized medicine, stating that HHS has received legal and monetary support which should allow for alternative and creative approaches to better personalized healthcare. They add that HHS will also play a critical role in the regulation of direct-to-consumer marketing of genetic tests, noting that it is important for those in the personalized medicine sector to familiarize themselves with the multiple roles that HHS plays.
